VAERS reports by lot

Moderna COVID-19 lot 013LZOA: VAERS reports

20 VAERS reports list lot 013LZOA as a Moderna COVID-19 vaccine, received between 2021-01-16 and 2022-07-29. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
10%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1628%
General / Systemic (non-local)1526%
Dermatological (non-injection-site)814%
Neurological47%
Gastrointestinal47%
Allergic / Anaphylactic35%
Musculoskeletal35%
Cardiac / Cardiovascular23%
Thrombotic / Hematological23%
Psychiatric / Neuropsychiatric12%

Where reports came from

U.S. state of the reporter, where given (top 10).

Pennsylvania4
New York3
Virginia2
South Carolina2
Indiana2
Maryland1
Georgia1
New Jersey1
Illinois1
Florida1

Reports by month received

2021-019
2021-024
2021-042
2021-051
2021-082
2022-021
2022-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.